Blacksmith Medicines Co-Founder Presents at the 21st International Conference on Biological Inorganic Chemistry
Presentation highlights Blacksmith’s novel chemistry platform for targeting metalloenzymes [...]
Presentation highlights Blacksmith’s novel chemistry platform for targeting metalloenzymes [...]
Patent protection covering clinical candidate FG-2101 composition of matter and [...]
SAN DIEGO, April 29, 2025 /PRNewswire/ -- Blacksmith Medicines, [...]
FG-2101 is Blacksmith’s non-hydroxamate small molecule inhibitor of LpxC [...]
SAN DIEGO, California, January 27, 2025 – Blacksmith Medicines, Inc. [...]